Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful monitoring and treatment of intraocular dissemination of acanthamoeba.

× No keyword cloud information.

11 in total

1. Cysticidal activity of antifungals against different genotypes of Acanthamoeba.

Authors: Alfonso Iovieno; Darlene Miller; Dolena R Ledee; Eduardo C Alfonso
Journal: Antimicrob Agents Chemother Date: 2014-07-07 Impact factor: 5.191

2. Treatment of intraocular spread of acanthamoeba after tectonic corneal graft in acanthamoeba keratitis.

Authors: Francisco Arnalich-Montiel; Maria Reyes-Batlle; Rogelio López-Vélez; Jacob Lorenzo-Morales
Journal: Eye (Lond) Date: 2018-02-23 Impact factor: 3.775

3. Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii.

Authors: Carmen M Martín-Navarro; Atteneri López-Arencibia; Ines Sifaoui; María Reyes-Batlle; Basilio Valladares; Enrique Martínez-Carretero; José E Piñero; Sutherland K Maciver; Jacob Lorenzo-Morales
Journal: Antimicrob Agents Chemother Date: 2015-03-02 Impact factor: 5.191

4. In vivo CNS infection model of Acanthamoeba genotype T4: the early stages of infection lack presence of host inflammatory response and are a slow and contact-dependent process.

Authors: Maritza Omaña-Molina; Dolores Hernandez-Martinez; Raquel Sanchez-Rocha; Ulises Cardenas-Lemus; Citlaltepetl Salinas-Lara; Adolfo Rene Mendez-Cruz; Laura Colin-Barenque; Patricia Aley-Medina; Jesus Espinosa-Villanueva; Leticia Moreno-Fierros; Jacob Lorenzo-Morales
Journal: Parasitol Res Date: 2016-12-03 Impact factor: 2.289

5. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).

Authors: David C Lamb; Andrew G S Warrilow; Nicola J Rolley; Josie E Parker; W David Nes; Stephen N Smith; Diane E Kelly; Steven L Kelly
Journal: Antimicrob Agents Chemother Date: 2015-05-26 Impact factor: 5.191

6. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.

Authors: Alfonso Martín Cabello-Vílchez; Carmen M Martín-Navarro; Atteneri López-Arencibia; María Reyes-Batlle; Ines Sifaoui; Basilio Valladares; José E Piñero; Jacob Lorenzo-Morales
Journal: Parasitol Res Date: 2013-11-22 Impact factor: 2.289

Review 7. CYP51 as drug targets for fungi and protozoan parasites: past, present and future.

Authors: Galina I Lepesheva; Laura Friggeri; Michael R Waterman
Journal: Parasitology Date: 2018-04-12 Impact factor: 3.234

8. Morphological Features and In Vitro Cytopathic Effect of Acanthamoeba griffini Trophozoites Isolated from a Clinical Case.

Authors: Arturo González-Robles; Lizbeth Salazar-Villatoro; Maritza Omaña-Molina; Maria Reyes-Batlle; Carmen M Martín-Navarro; Jacob Lorenzo-Morales
Journal: J Parasitol Res Date: 2014-09-08

Review 9. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors: Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal: Parasite Date: 2015-02-18 Impact factor: 3.000

10. Rapid resolution of stromal keratitis with the assistance of oral voriconazole in resistant acanthamoeba keratitis.

Authors: Tzu-Yu Hou; Yun-Chen Chen; Chih-Chien Hsu
Journal: Taiwan J Ophthalmol Date: 2017 Oct-Dec